POPULARITY
Interview with Jay F. Piccirillo, MD, and Azadeh Afshari, DDS, authors of Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring
Interview with Jay F. Piccirillo, MD, and Azadeh Afshari, DDS, authors of Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by Associate Editor Jacob Hunter, MD, and senior author Jay F. Piccirillo, MD, for a discussion of the article “Identifying Predictors of Treatment Response in Meniere's Disease: A Clinical Severity Staging System,” which published in the January 2024 issue of Otolaryngology–Head and Neck Surgery. Their conversation highlights how decreased vertigo severity, reduced comorbidity burden, and absence of hearing loss are associated with conservative treatment response in Meniere's disease. Click here to read the article.
Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
In the year since COVID-19 infections first appeared in the United States, a few things have become clear. One is that many who get sick don’t recover quickly. Even those who don’t have to be hospitalized can experience symptoms that linger. Called long-haulers, these individuals suffer from a variety of issues such as shortness of breath, abnormal heart rhythms, fatigue and loss of the ability to smell. In fact, many people first realize they may be infected with the virus when they notice they’ve lost the ability to taste and smell food. For most, these symptoms disappear quickly, but some people continue to struggle. Doctors and researchers at the School of Medicine are working with long-haulers to help them deal with these lasting effects of the SARS-CoV-2 virus. In this episode, we’ll hear from ear, nose & throat specialist Jay F. Piccirillo, MD, a professor of otolaryngology and the department’s vice chair for research. He is conducting several studies involving long-haulers, trying to help them regain the ability to smell. We’ll also hear from Amanda K. Verma, MD, an assistant professor of medicine and a cardiologist who normally works with very sick patients whose heart disease has made them candidates for implanted heart assist devices or even transplants. Over the last year, she’s seen many long-haul COVID-19 patients who have developed problems similar to those faced by heart transplant patients. The podcast, “Show Me the Science,” is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.
Interview with Jay F. Piccirillo, MD, author of A Novel Treatment for Tinnitus and Tinnitus-Related Cognitive Difficulties Using Computer-Based Cognitive Training and D-Cycloserine
Interview with Jay F. Piccirillo, MD, author of Amoxicillin for Acute Rhinosinusitis: A Randomized Controlled Trial